Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Multi-virus CRISPR screening data in VeroE6 cells

ABSTRACT: Multi-virus CRISPR screening data in VeroE6 cells

PROVIDER: PRJNA704329 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR13770540.fastq.gz	Fastqsanger.gz
	SRR13770541.fastq.gz	Fastqsanger.gz
	SRR13770542.fastq.gz	Fastqsanger.gz
	SRR13770543.fastq.gz	Fastqsanger.gz
	SRR13770544.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 31

Similar Datasets

CRISPR Screening in Glioblastoma

Project description:This is an in vitro genome-wide CRISPR/cas9 screen in human glioblastoma stem cells, screening for genes essential for survival of these cells. These cells express cas9 and have been transfected with a guide RNA library causing gene knockouts. We will analyse the sequencing data for depletion of guide RNAs. In this particular study, we will do RNA sequencing to correlate CRISPR with expression levels in specific cancer cell subpopulations. This data is part of a pre-publication release. For information on the proper use of pre-publication data shared by the Wellcome Trust Sanger Institute (including details of any publication moratoria), please see http://www.sanger.ac.uk/datasharing/

2016-03-22 | E-ERAD-448 | biostudies-arrayexpress

Multi-virus CRISPR screening data in VeroE6 cells

Project description:We report the results of CRISPR survival screens in the context of multiple viral infections. Two sgRNA pools were used: one targeting the SARS-CoV-2 RNA interactome proteins, and one targeting mitochondrially-related proteins.

2021-02-24 | GSE167334 | GEO

CRISPR knockout screening data and RNAsequencing in LINE-1(+) RPE cells

Project description:CRISPR knockout screening data and RNAsequencing in LINE-1(+) RPE cells

| PRJNA491205 | ENA

A multi-functional AAV-CRISPR-Cas9 and its host response

Project description:CRISPR-Cas9 delivery by AAV holds promise for gene therapy but faces critical barriers due to its potential immunogenicity and limited payload capacity. Here, we demonstrate genome engineering in postnatal mice using AAV-split-Cas9, a multi-functional platform customizable for genome-editing, transcriptional regulation, and other previously impracticable AAV-CRISPR-Cas9 applications. We identify crucial parameters that impact efficacy and clinical translation of our platform, including viral biodistribution, editing efficiencies in various organs, antigenicity, immunological reactions, and physiological outcomes. These results reveal that AAV-CRISPR-Cas9 evokes host responses with distinct cellular and molecular signatures, but unlike alternative delivery methods, does not induce detectable cellular damage in vivo. Our study provides a foundation for developing effective genome therapeutics mRNA-Seq from muscles (9 samples; 3 mice x 3 conditions) and lymph nodes (9 samples; 3 mice x 3 conditions).

2016-07-29 | E-GEOD-84534 | biostudies-arrayexpress

Transposon mutagenesis screening of Sendai virus and mumps virus

Project description:Transposon mutagenesis screening of Sendai virus and mumps virus

| PRJNA515704 | ENA

CRISPR screen for the identification of host factors for ZIKA virus infection

Project description:To search for host factors regulating Zika virus infection, we performed a genome-wide loss-of-function CRISPR/Cas9 screen in haploid human ESCs. The regulators were identified by the quantification of enrichment of their mutant clones within a pooled loss-of-function library upon Zika virus infection.

2023-05-31 | E-MTAB-11945 | biostudies-arrayexpress

Genome-Scale CRISPR Knockout Screening Identifies BACH1 as a Key Regulator of Aflatoxin B1-Induced Oxidative Damage

Project description:Overall data for CRISPR screening + RNA-Seq

2022-03-25 | GSE199386 | GEO

CRISPR screening of porcine sgRNA library identifies host factors associated with Japanese encephalitis virus replication

Project description:CRISPR screening of porcine sgRNA library identifies host factors associated with Japanese encephalitis virus replication

| PRJNA664556 | ENA

CRISPR-StAR, a paradigm leveraging internal controls, empowers genetic screening in vivo (batch 2)

Project description:Pooled genetic screening with CRISPR/Cas9 has enabled genome-wide high-resolution assignment of genes to phenotypes. To assess the effect of a given genetic perturbation, each sgRNA must be evaluated in hundreds of cells to overcome stochastic genetic drift and obtain robust results. In complex models that display particularly high heterogeneity, such as organoids or tumors transplanted into mice however, sufficient representation typically requires unreasonable scaling, thus preventing genome-wide screens at high resolution. Here we present CRISPR-StAR, a screening paradigm that overcomes intrinsic and extrinsic heterogeneity as well as genetic drift in bottlenecks by leveraging internal controls generated through activating sgRNAs only in half of the progenies of each cell. We use CRISPR-StAR to reveal in vivo-specific genetic dependencies in a genome-wide screen in mouse melanoma. Benchmarking to a conventional screening setup highlights the improved data quality this technology delivers. We anticipate CRISPR-StAR to set a new standard for genetic screening in complex models, foremost in vivo.

2024-11-05 | GSE262308 | GEO

CRISPR-StAR, a paradigm leveraging internal controls, empowers genetic screening in vivo (batch 1)

2024-11-05 | GSE262307 | GEO